AES-350 is a potent and selective HDAC6 inhibitor. AES-350 demonstrated greater HDAC isoform selectivity, higher cytotoxicity in MV4-11 cells, an improved therapeutic window, and more efficient absorption through cellular and lipid membranes. AES-350 also demonstrated improved oral bioavailability compared to SAHA in mouse models. AES-350 exhibited an in vitro HDAC6 selectivity profile comparable to that of ricolinostat and citarinostat.
MedKoo Cat#: 408056
Name: AES-350
CAS#: 847249-57-4
Chemical Formula: C18H20N2O3
Exact Mass: 312.1474
Molecular Weight: 312.37
Elemental Analysis: C, 69.21; H, 6.45; N, 8.97; O, 15.37
The following data is based on the product molecular weight 312.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |